StockTipsArenaBeta

BUY Divi's Laboratories Limited — Amit Shreeram Goel

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byAmit Shreeram GoelHorizon: NA (inferred Swing (≤2wk))30 Oct 2026via NDTV Profit (Live)

Entry₹9,680Inferred
Target₹10,500
Total upside +8.47%
Stop loss₹9,260-4.34% risk
CMP₹9,7805h ago
Active+1.03%+7.36%upside left 14d left
Follow Amit Shreeram Goel for new calls(21% target hit, 48 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alertsSee 2 other Swing calls on DIVISLABSee 235 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Oct, 9:22 pm IST
4 supporting1 neutral0 opposing
Supports the BUY call (4)

MACD above its signal line — bullish momentum

Technicals · macd·30 Oct · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·28 Oct · 2d ago

Divi's Laboratories shares in focus as weight loss drug receives EU panel backing

NewsCnbc-Tv18·19 Oct · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·26 Aug · 2mo ago

Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 07 Nov 2026

BSE · Board Meeting·In 7 days

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Amit Shreeram Goel

Every call and its outcome